Literature DB >> 8286838

Metabolic bone disease (anticonvulsant osteomalacia) and renal tubular acidosis in tuberous sclerosis.

J P Radó1, A Haris.   

Abstract

The characteristics triad of tuberous sclerosis-adenoma sebaceum, mental deficiency and epilepsy-associated with distal-type renal tubular acidosis was combined with anticonvulsant osteomalacia in a 41-year-old woman. In addition to the specific bone lesions of tuberous sclerosis, the bone disease was caused by an adverse effect of a drug and possibly also by the renal disorder leading to significant musculoskeletal disability. In response to calcium carbonicum and 1-25-dihydroxyvitamin D therapy the musculoskeletal disability healed and the abnormal biochemical markers of anticonvulsant osteomalacia disappeared. The present observation draws attention to the increased hazard threatening patients on chronic anticonvulsant therapy simultaneously suffering from renal diseases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8286838     DOI: 10.2169/internalmedicine.32.574

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Calcitriol Reverses the Down-Regulation Pattern of Tuberous Sclerosis Complex Genes in an In Vitro Calcification Model.

Authors:  Eraldo Fonseca Dos Santos Junior; Roberta Rodrigues de Lemos Gitirana; Darlene Paiva Bezerra; João Ricardo Mendes de Oliveira
Journal:  J Mol Neurosci       Date:  2017-12-11       Impact factor: 3.444

2.  Cutaneous manifestations of tuberous sclerosis.

Authors:  Sue Hake
Journal:  Ochsner J       Date:  2010

3.  Fracture epidemiology and control in a developmental center.

Authors:  G S Lohiya; F M Crinella; L Tan-Figueroa; S Caires; S Lohiya
Journal:  West J Med       Date:  1999-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.